TY  - GEN
AU  - Turk,Anita A
AU  - Wisinski,Kari B
TI  - PARP inhibitors in breast cancer: Bringing synthetic lethality to the bedside
SN  - 1097-0142
PY  - 2019///0926
KW  - Antineoplastic Agents, Immunological
KW  - pharmacology
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - BRCA1 Protein
KW  - genetics
KW  - BRCA2 Protein
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Cell Survival
KW  - drug effects
KW  - Clinical Trials as Topic
KW  - DNA Repair
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Humans
KW  - Molecular Targeted Therapy
KW  - methods
KW  - Patient Selection
KW  - Poly(ADP-ribose) Polymerase Inhibitors
KW  - Poly(ADP-ribose) Polymerases
KW  - metabolism
KW  - Synthetic Lethal Mutations
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
UR  - https://doi.org/10.1002/cncr.31307
ER  -